Company Cryo-Cell International, Inc. Other OTC
Equities
CCEL
US2288951088
Healthcare Facilities & Services
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Umbilical Cord Blood and Cord Tissue Stem Cell Service
98.3
%
| 30 | 98.1 % | 31 | 98.3 % | +3.44% |
Public Cord Blood Banking
1.5
%
| 0 | 1.5 % | 0 | 1.5 % | +4.23% |
PrepaCyte Cord Blood
0.2
%
| 0 | 0.3 % | 0 | 0.2 % | -36.10% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 30 | 100.0 % | 31 | 100.0 % | +3.32% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Portnoy
CEO | Chief Executive Officer | 60 | 11-07-31 |
David Portnoy
CEO | Chief Executive Officer | 61 | 11-07-31 |
Jill Taymans
DFI | Director of Finance/CFO | 55 | 97-03-31 |
Joanne Kurtzberg
CTO | Chief Tech/Sci/R&D Officer | - | 17-12-31 |
Oleg Mikulinsky
CTO | Chief Tech/Sci/R&D Officer | 50 | 12-03-04 |
Irene Smith
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Portnoy
CEO | Chief Executive Officer | 61 | 11-07-31 |
Mark Portnoy
CEO | Chief Executive Officer | 60 | 11-07-31 |
Harold Berger
BRD | Director/Board Member | 60 | 11-08-24 |
Daniel Mizrahi
BRD | Director/Board Member | 50 | 21-09-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,698,746 | 3,868,118 ( 26.32 %) | 6,594,269 ( 44.86 %) | 26.32 % |
Company contact information
Cryo-Cell International, Inc.
700 Brooker Creek Boulevard Suite 1800
34677, Oldsmar
+813 749 2100
http://www.cryo-cell.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+13.70% | 81.4B | |
-29.20% | 70.18B | |
+9.72% | 29.08B | |
-11.43% | 16.97B | |
-0.43% | 16.96B | |
-0.31% | 15.26B | |
+3.42% | 12.41B | |
+28.34% | 11.79B | |
-30.70% | 11.95B |